Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1891-1900 of 2244 for

Edit search filters
  1. A Study to Evaluate Chemotherapy-Induced Nausea in Breast Cancer Patients

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN, Albert Lea, MN, Mankato, MN

  2. Cervical Cancer Screening Among Populations With Health Disparities

    Rochester, MN

  3. Evaluating Intraoperative Indocyanine Green Dye Fluorescence Angiography for Sarcoma Resectiong

    Rochester, MN

  4. Broad Evidence of Systemic Immune Activation in Long Term Survivors of Advanced Ovarian Cancer

    Rochester, MN

  5. Pancreatic Cancer Detection Consortium

    Rochester, MN

  6. Tools to evaluate treatment tolerability in older patients with sarcoma

    Rochester, MN

  7. Mindfulness-Based Intervention (Muse-S™) as an Adjunct During Diagnostic Work-up in Patients Presenting to the Undiagnosed Mass Clinic (UMC).

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. Breast Cancer Genome Guided Therapy Study (BEAUTY)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments

    Jacksonville, FL

  10. Metabolite Levels in Ovarian Cancer Patients Receiving Maintenance PARP Inhibitors

    Rochester, MN

.

Mayo Clinic Footer